# Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

> **NCT00004008** · PHASE2 · COMPLETED · sponsor: **University of Glasgow**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** bryostatin 1

## Key facts

- **NCT ID:** NCT00004008
- **Lead sponsor:** University of Glasgow
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004008, "Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*